*You must be registered for the ANA2021 Virtual Annual Meeting to access the live SIG Series sessions.

Date/Time ET: Friday, November 5, 2021 - 11:30 AM  – 1:00 PM

Session Title: Epilepsy Genetics: Bringing Basic Science to the Clinic

Description: Speakers will discuss the epilepsy genetics from preclinical research to clinical applications. Preclinical research focused on the development of antisense oligonucleotide therapy, precision medicine in rare genetic disorders, somatic variants in the brain and non-monogenetic epilepsy will be discussed. Finally, we will discuss the utilization of genetics in clinical practice.

Chair: Kathryn Davis, MD, MS, FAES, University of Pennsylvania

Co-Chair: Chloe Hill, MD, MS, University of Michigan


  • Utilize genetics data in epilepsy patients
  • Understand ongoing ASO genetic trials
  • Understand how to diagnose and treat patients with underlying genetic causes of their epilepsy


Dancing to a Different Tune: TANGO Gives Hope for Dravet Syndrome


Lori Isom, PhD

University of Michigan, Medical School

Pv+ Interneurons Are Non-Cell Autonomously Dysregulated in Depdc5-Associated Epilepsies

Oral Presenter:

Tao Yang, PhD

University of Michigan, Department of Neurology

Precision Diagnosis in Epilepsy--a First Step Toward Precision Medicine


Ann Poduri, MD, MPH

Boston Children's Hospital, Harvard Medical School

Non-cell Autonomous Hyperexcitability Underlies Focal Epileptogenesis Mediated by Low-level Brain Somatic Mutations in Mtor

Oral Presenter:

Hyunyong Koh, MD, PhD

Boston Children's Hospital

Genetics in the Clinic: Beyond Monogenic Epilepsies


Colin Ellis, MD

University of Pennsylvania

Continuing Medical Education

The American Neurological Association hosts a wide range of educational programs. These programs seek to enhance the development and success of those pursuing a career in academic neurology at all levels. There are educational offerings to benefit those at the beginning stages of their careers, including students and those in their first faculty position, as well as those looking for best practices in Chair level positions. These programs seek to enhance attendee success in the field of academic neurology and to contribute to the overall education of neurologists and neuroscientists.

The Special Interest Groups offer CME to eligible participants. Click here to see a complete breakdown of how many credits are available per session.

ACCME Accreditation, AMA Designation, and MIPS Statements **Pertaining to Each Session Awarding CME**

The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Neurological Association designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).


Instructions For Obtaining CME

Following the event, the evaluation and credit claiming system will open in OnDEC. Please complete the online evaluation by 12/31/2021 to obtain CME credit. You will be provided with a certificate after completing the evaluation. If you have any questions, please contact the ANA Meeting Coordinator at: meetings@myana.org

Click here to see a complete breakdown of how many credits are available per session.

Financial Disclosure Statements

The planners and faculty for this activity do not have any relationships to disclose unless listed here. Any relevant relationships with ACCME-defined ineligible companies will be mitigated according to ACCME Standards prior to the start of the activity.

Disclosure of Commercial Support

ANA received educational grants from the following ACCME-defined ineligible companies to support the CME aspects of this event: Added as confirmed.

DISCLAIMER: The ANA does not endorse or affiliate with third-party companies, products or services including those that may have elected to support the Special Interest Groups.